Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma. (Q43761368)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593335%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593335%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593335%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

C Fels

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593335%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

J W Droege

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593335%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

C Schäfer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593335%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

C M Kramm

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593335%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

T C Chou

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593335%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 September 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593335%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593335%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593335%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593335%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

662-668

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593335%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700355

12 November 2019

exact match

0 references

cites work

Brain cancer incidence, mortality and case survival: observations from two Australian cancer registries.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700355

7 January 2021

Patient age, histologic features, and length of survival in patients with glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700355

7 January 2021

The basis for current treatment recommendations for malignant gliomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700355

7 January 2021

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700355

7 January 2021

Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700355

7 January 2021

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700355

7 January 2021

A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700355

7 January 2021

A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700355

7 January 2021

Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700355

7 January 2021

Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700355

7 January 2021

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700355

7 January 2021

The Charing Cross Hospital experience with temozolomide in patients with gliomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700355

7 January 2021

Generalized Equations for the Analysis of Inhibitions of Michaelis-Menten and Higher-Order Kinetic Systems with Two or More Mutually Exclusive and Nonexclusive Inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700355

7 January 2021

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700355

7 January 2021

Drug combinations: from laboratory to practice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700355

7 January 2021

Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700355

7 January 2021

Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700355

7 January 2021

Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700355

7 January 2021

Intracellular Localization and intercellular heterogeneity of the human DNA repair protein O(6)-methylguanine-DNA methyltransferase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700355

7 January 2021

Acyclic guanosine analogs inhibit DNA polymerases alpha, delta, and epsilon with very different potencies and have unique mechanisms of action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700355

7 January 2021

Phase I and pharmacokinetic study of temozolomide on a daily-for-5-days schedule in patients with advanced solid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700355

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11593335%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

12 November 2019

0 references

1 reference